Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers

被引:35
作者
Furlan, PM [1 ]
Kallan, MJ [1 ]
Ten Have, T [1 ]
Pollock, BG [1 ]
Katz, I [1 ]
Lucki, I [1 ]
机构
[1] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
D O I
10.1176/appi.ajgp.9.4.429
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Tbe authors evaluated the cognitive and psychomotor effects of serotonin reuptake inhibitors in health elderly volunteers. Paroxetine, sertraline, and placebo were compared for 3 weeks of testing in a double-blind study with behavioral testing at baseline and at the end of each week. MANOVA models demonstrated no between-group differences; however, mixed-model random regression analyses revealed that Day 14 plasma paroxetine levels correlated negatively with delayed verbal recall and paired-associate learning scores. In contrast, plasma sertraline levels correlated positively with Day 7 immediate verbal recall, Day 14 tapping, and Day 21 delayed verbal recall scores, and negatively with divided-attention task scores on Day 21. Plasma paroxetine levels were associated with mild behavioral impairment at Day 14, with no other significant adverse effects. Plasma sertraline levels were associated with mild and transient behavioral changes, as well as early termination in several subjects.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 28 条
[1]  
[Anonymous], 1955, MANUAL WECHSLER ADUL
[2]   Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection [J].
Foglia, JP ;
Sorisio, D ;
Kirshner, M ;
Pollock, BG .
JOURNAL OF CHROMATOGRAPHY B, 1997, 693 (01) :147-151
[3]  
GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739
[4]   PHARMACOLOGICAL CHARACTERIZATION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) [J].
HYTTEL, J .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 :19-26
[5]   RELIABILITY AND FACTOR-ANALYSIS OF THE EPWORTH SLEEPINESS SCALE [J].
JOHNS, MW .
SLEEP, 1992, 15 (04) :376-381
[6]   A REVIEW OF THE METABOLISM AND PHARMACOKINETICS OF PAROXETINE IN MAN [J].
KAYE, CM ;
HADDOCK, RE ;
LANGLEY, PF ;
MELLOWS, G ;
TASKER, TCG ;
ZUSSMAN, BD ;
GREB, WH .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 :60-75
[7]  
LANE MR, 1999, GERMAN J PSYCHIAT, V2, P1
[8]  
Loi CM, 1997, J PHARMACOL EXP THER, V280, P627
[9]  
LUCKI I, 1986, PSYCHOPHARMACOLOGY, V88, P426
[10]  
MATTILA MJ, 1988, J CLIN PSYCHIAT, V49, P52